PMID: 8582128Nov 1, 1995Paper

Development and progression of diabetic retinopathy: adolescents at risk

Diabetic Medicine : a Journal of the British Diabetic Association
M BonneyMartin Silink

Abstract

The aims of this study were to evaluate short-term changes in retinopathy in adolescents, and to examine the relationship of these changes to risk factors. Two-hundred and three adolescents, with a median age of 14.5 (range 10.4 to 20.6) yr and a median duration of diabetes of 6.6 (1.1 to 16.3) yr, were included in the study. Retinopathy was assessed on two occasions, using stereoscopic fundus photography; the median time between assessment was 1.3 (0.5 to 3.0) yr. At baseline, 41% of the adolescents had background retinopathy. When patients were stratified according to the median diabetes duration (DD) (6.6 yr) and glycaemic control over the 12 months prior to assessment (HbA1C) (8.4%), the percentage of retinopathy in each group was: lowDD/lowHbA1C 13%; lowDD/highHbA1C 40%; highDD/lowHbA1C 42%; and highDD/highHbA1C 72%. Using a 2-step criteria for stability or change in retinopathy, 11% of the 203 adolescents showed progression of retinopathy, 41% had stable retinopathy, 5% showed regression, and 43% had no retinopathy at either assessment. Change in retinopathy was related to age at baseline assessment (borderline significance, p = 0.06), diabetes duration (p < 0.001), glycaemic control (p < 0.001) and total cholesterol (p =...Continue Reading

References

Dec 1, 1992·Diabetes Care·M D Davis
Apr 1, 1991·Diabetic Medicine : a Journal of the British Diabetic Association
Feb 1, 1990·Ophthalmology·H P ChaseM J Crews
Nov 18, 1988·JAMA : the Journal of the American Medical Association·R KleinD L DeMets
Jan 7, 1988·Diabetes Research and Clinical Practice·L A KingsleyA L Drash
Jul 1, 1985·Diabetes Care·R KleinD L DeMets
Jun 1, 1984·Journal of Clinical Pathology·D Q BorseyB F Clarke
Jun 20, 1994·The Medical Journal of Australia·J M FairchildM Silink
Dec 1, 1993·Diabetic Medicine : a Journal of the British Diabetic Association·P G McNallyA C Burden
Sep 30, 1993·The New England Journal of Medicine·UNKNOWN Diabetes Control and Complications Trial Research GroupC Siebert

❮ Previous
Next ❯

Citations

Oct 8, 1999·Clinica Chimica Acta; International Journal of Clinical Chemistry·A Fagot-CampagnaD F Williamson
May 4, 2012·Diabetes Technology & Therapeutics·Anandakumar AmuthaViswanathan Mohan
May 1, 2012·Survey of Ophthalmology·Sobha SivaprasadJennifer Evans
May 20, 2003·Diabetic Medicine : a Journal of the British Diabetic Association·D M BartonT A M Abdu
May 29, 1998·The Journal of Pediatrics·W Cutfield
Feb 24, 2001·Diabetes Care·N ChaturvediUNKNOWN EURODIAB Prospective Complications Study
Mar 1, 2005·Diabetes Care·Ann MaguireKim Donaghue
Dec 24, 2004·Diabetes Care·Janet SilversteinUNKNOWN American Diabetes Association
Dec 31, 2015·Clinical & Experimental Ophthalmology·Daniel Shu Wei TingTien Yin Wong
Nov 18, 2016·Indian Journal of Ophthalmology·Handan AkilMehmet Numan Alp
Jul 7, 1999·Journal of Pediatric Endocrinology & Metabolism : JPEM·K C DonaghueM Silink
Apr 9, 1999·Acta Paediatrica. Supplement·O Kordonouri, T Danne
Jul 1, 1995·Diabetes/metabolism Reviews·R L Engerman, T S Kern
Nov 20, 1998·Acta Paediatrica. Supplement·T DanneG Hövener
May 29, 2008·Arquivos brasileiros de endocrinologia e metabologia·Jorge EstevesLuís H Canani
Jun 2, 2018·International Journal of Endocrinology·P Ruiz-OcañaA M Lechuga-Sancho
May 1, 1997·Journal of Pediatric Endocrinology & Metabolism : JPEM·H B Mortensen, P Hougaard
Apr 16, 2021·Endocrinology, Diabetes & Metabolism·Bedowra ZabeenKishwar Azad

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diabetes & Tolerance

Patients with type I diabetes lack insulin-producing beta cells due to the loss of immunological tolerance and autoimmune disease. Discover the latest research on targeting tolerance to prevent diabetes.